OraSure Technologies (NASDAQ:$OSUR) announced today that their president and CEO, Douglas A. Michels will speak at the Cantor Fitzgerald Global Healthcare Conference for 2017. Mr. Michels will speak on September 26 at approximately 11:15 AM PT). The conference will also feature a webcast that can be accessed from OraSure Technologies’ website, as well as a replay that will be available for seven days after the event.
The company specializing in the design, production, and distribution of technology for the diagnosis of various illness using patient’s saliva. Their products include tests for HIV, HCV, and drug abuse.
OSUR sells products to a wide array of customers, including clinics, hospitals, community-based organizations, public health organizations, academic institutes, government agencies, industrial entities, clinical labs, and even consumers.
They currently have a $1.3 billion market cap, and 59,459 outstanding shares. They have a moving average price of $20.72 and $16.80 on a 50 and 200-day scale, respectively, with prices currently at $21.94.
Featured Image: twitter
